Drug delivery system
CA 2511573 A1 · Owner: Novartis Ag · Inventors: Prescott, Margaret Forney
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A drug delivery device or system comprising: a) a medical device e.g. a , coated stent or stent-graft, adapted for local application or administration in hollow tubes; and, in conjunction therewith b) a therapeutic dosage of an , anti-inflammatory ascomycin derivative such as pimecrolimus, e.g. affixed to the medical device, and use thereof in the preparation of a medicament for the prevention and treatment of inflammatory complications following vascular injury, and method of treatment therewith.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.